ATE479675T1 - Wasserlösliche thalidominderivate - Google Patents

Wasserlösliche thalidominderivate

Info

Publication number: ATE479675T1
Authority: AT; Austria
Prior art keywords: chr; thalidomine; derivatives; water soluble; alkyl
Prior art date: 2003-03-27

Application number

AT04717008T

Other languages

English (en)

Inventor

Hesheng Zhang

Original Assignee

Tian Jin Hemay Bio Tech Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-27

Filing date

2004-03-04

Publication date

2010-09-15

2004-03-04 Application filed by Tian Jin Hemay Bio Tech Co Ltd filed Critical Tian Jin Hemay Bio Tech Co Ltd

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE479675T1 publication Critical patent/ATE479675T1/de

Links

XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
-1 1,3-propylene, 1,4-butylene, 1,5-pentylene, 1,6-hexylene Chemical group 0.000 abstract 1
UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical class O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 abstract 1
239000008186 active pharmaceutical agent Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Artificial Filaments (AREA)

AT04717008T 2003-03-27 2004-03-04 Wasserlösliche thalidominderivate ATE479675T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CNB031209947A CN100488959C (zh)	2003-03-27	2003-03-27	水溶性的酞胺哌啶酮衍生物
PCT/CN2004/000167 WO2004085422A1 (en)	2003-03-27	2004-03-04	Water-soluble thalidomine derivatives

Publications (1)

Publication Number	Publication Date
ATE479675T1 true ATE479675T1 (de)	2010-09-15

Family

ID=33035142

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04717008T ATE479675T1 (de)	2003-03-27	2004-03-04	Wasserlösliche thalidominderivate

Country Status (12)

Country	Link
US (1)	US7741342B2 (de)
EP (1)	EP1607394B1 (de)
JP (1)	JP4703554B2 (de)
CN (1)	CN100488959C (de)
AT (1)	ATE479675T1 (de)
AU (1)	AU2004224271B2 (de)
BR (1)	BRPI0408675A (de)
CA (1)	CA2519051A1 (de)
DE (1)	DE602004028917D1 (de)
ES (1)	ES2349372T3 (de)
WO (1)	WO2004085422A1 (de)
ZA (1)	ZA200506797B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1389203B8 (de)	2001-02-27	2010-03-10	The Governement of the United States of America, represented by The Secretary Department of Health and Human services	Analoga von thalidomid als angiogeneseinhibitoren
WO2005016326A2 (en) *	2003-07-11	2005-02-24	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Analogs of thalidomide as potential angiogenesis inhibitors
US8952895B2 (en)	2011-06-03	2015-02-10	Apple Inc.	Motion-based device operations
WO2005028436A2 (en)	2003-09-17	2005-03-31	The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Thalidomide analogs as tnf-alpha modulators
CN100383139C (zh) *	2005-04-07	2008-04-23	天津和美生物技术有限公司	可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物
EP2358697B1 (de) *	2008-10-29	2015-10-21	Celgene Corporation	Isoindolin-verbindungen zur behandlung von krebs
US8927725B2 (en)	2011-12-02	2015-01-06	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Thio compounds
CA3045703C (en) *	2016-11-24	2021-11-02	Tianjin Hemay Bio-Tech Co., Ltd	Piperidine-2,6-dione derivatives and ulcerative colitis treating
US20200199097A1 (en) *	2017-08-21	2020-06-25	Nanjing Noratech Pharmaceuticals Co., Ltd	Pomalidomide derivative and preparation method therefor
CN111499610A (zh) *	2019-01-31	2020-08-07	南京诺瑞特医药科技有限公司	泊马度胺前体药物盐的多晶型物
CN110028439B (zh) *	2019-04-25	2020-11-13	四川大学	邻苯二甲酰亚胺类衍生物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992018496A1 (de) *	1991-04-17	1992-10-29	Grünenthal GmbH	Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln
DE19613976C1 (de) *	1996-04-09	1997-11-20	Gruenenthal Gmbh	Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
CN100383139C (zh) *	2005-04-07	2008-04-23	天津和美生物技术有限公司	可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物

2003
- 2003-03-27 CN CNB031209947A patent/CN100488959C/zh not_active Expired - Fee Related
2004
- 2004-03-04 AT AT04717008T patent/ATE479675T1/de not_active IP Right Cessation
- 2004-03-04 JP JP2006504195A patent/JP4703554B2/ja not_active Expired - Fee Related
- 2004-03-04 US US10/547,054 patent/US7741342B2/en not_active Expired - Fee Related
- 2004-03-04 CA CA002519051A patent/CA2519051A1/en not_active Abandoned
- 2004-03-04 AU AU2004224271A patent/AU2004224271B2/en not_active Ceased
- 2004-03-04 DE DE602004028917T patent/DE602004028917D1/de not_active Expired - Lifetime
- 2004-03-04 EP EP04717008A patent/EP1607394B1/de not_active Expired - Lifetime
- 2004-03-04 BR BRPI0408675-9A patent/BRPI0408675A/pt not_active IP Right Cessation
- 2004-03-04 ES ES04717008T patent/ES2349372T3/es not_active Expired - Lifetime
- 2004-03-04 WO PCT/CN2004/000167 patent/WO2004085422A1/zh not_active Ceased
2005
- 2005-08-24 ZA ZA200506797A patent/ZA200506797B/en unknown

Also Published As

Publication number	Publication date
JP4703554B2 (ja)	2011-06-15
DE602004028917D1 (de)	2010-10-14
ES2349372T3 (es)	2010-12-30
JP2006521295A (ja)	2006-09-21
ZA200506797B (en)	2006-05-31
US7741342B2 (en)	2010-06-22
AU2004224271B2 (en)	2010-02-18
CA2519051A1 (en)	2004-10-07
EP1607394A4 (de)	2008-06-25
EP1607394B1 (de)	2010-09-01
AU2004224271A1 (en)	2004-10-07
BRPI0408675A (pt)	2006-03-28
CN100488959C (zh)	2009-05-20
EP1607394A1 (de)	2005-12-21
WO2004085422A1 (en)	2004-10-07
CN1534035A (zh)	2004-10-06
US20060094730A1 (en)	2006-05-04

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE260255T1 (de)	2004-03-15	5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69528005D1 (de)	2002-10-10	Prolineamid-Derivate
ATE126795T1 (de)	1995-09-15	Benzopyranderivate und verfahren zu ihrer herstellung.
DE69519921D1 (de)	2001-02-22	Imidazolidin-derivate und ihre verwendung
EP0767170A4 (de)	1998-08-05	4,6-diarylpyrimidin-derivate und deren salze
ATE245152T1 (de)	2003-08-15	Dioxocyclopentylhydroxamsäure
MXPA02012034A (es)	2003-04-25	Derivados de tiofeno utiles como agentes anticancerosos.
DE69820248D1 (de)	2004-01-15	Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
ATE234099T1 (de)	2003-03-15	Immununterdrückende effekte von 8 substituierten xanthinderivaten
DE60027015D1 (en)	2006-05-18	Pseudoerythromycin-derivate
AR022469A1 (es)	2002-09-04	Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
NO2011026I2 (no)	2012-06-11	Eribulin eller et farmasøytisk akseptabelt salt derav
BRPI0408675A (pt)	2006-03-28	derivados de talidomida solúveis em água
EP1314719A4 (de)	2005-09-21	Benzoesäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PT992509E (pt)	2004-12-31	Novos derivados macrolidos
DE3882895D1 (de)	1993-09-09	Imid-derivate, ihre herstellung und verwendung.
ATE89739T1 (de)	1993-06-15	Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
EP1434762A4 (de)	2006-01-04	4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
FI97883B (fi)	1996-11-29	Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
PA8558901A1 (es)	2003-06-30	Nuevos compuestos hexaciclicos
DK0551844T3 (da)	1999-04-12	Svovlholdige galdesyrederivater
ES2168119T3 (es)	2002-06-01	Derivados de quinoxalina para el tratamiento de tinnitus.
ATE380028T1 (de)	2007-12-15	Mittel zur anregung des appetits und mittel zur behandlung von anorexie
ATE243219T1 (de)	2003-07-15	9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
DE60230924D1 (de)	2009-03-05	2-substituierte vitamin-d-derivate